Search hospitals > Florida > Miami
Novartis Investigative Site
Claim this profileMiami, Florida 33136
Global Leader in Multiple Sclerosis
Global Leader in Obstructive Lung Diseases
Conducts research for Chronic Obstructive Pulmonary Disease
Conducts research for Lung Disease
Conducts research for Arthritis
123 reported clinical trials
1 medical researcher
Summary
Novartis Investigative Site is a medical facility located in Miami, Florida. This center is recognized for care of Multiple Sclerosis, Obstructive Lung Diseases, Chronic Obstructive Pulmonary Disease, Lung Disease, Arthritis and other specialties. Novartis Investigative Site is involved with conducting 123 clinical trials across 119 conditions. There are 1 research doctors associated with this hospital, such as Melvin Martinez-Castrillon.Top PIs
Clinical Trials running at Novartis Investigative Site
Multiple Sclerosis
Cardiovascular Disease
Acute Myeloid Leukemia
Coronary Artery Disease
Chronic Urticaria
Autoimmune Inflammation
Inflammation
Acute Coronary Syndrome
Syndrome
Atherosclerosis
Remibrutinib vs Teriflunomide
for Multiple Sclerosis
This trial compares remibrutinib and teriflunomide in patients with relapsing multiple sclerosis. It aims to find out which medication is more effective and safer. Both drugs work by controlling the immune system to reduce relapses. Teriflunomide is an approved treatment for adults with this condition.
Recruiting2 awards Phase 3
Remibrutinib vs Teriflunomide
for Multiple Sclerosis
This trial compares two medications, remibrutinib and teriflunomide, for treating patients with relapsing multiple sclerosis. These patients have repeated episodes of symptoms and need effective treatments. The medications work by controlling the immune system to prevent it from causing damage to the nervous system. Teriflunomide is an approved medication for adults with relapsing multiple sclerosis.
Recruiting2 awards Phase 3
Ofatumumab
for Multiple Sclerosis
The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have participated in a Novartis ofatumumab clinical MS study. Vaccination sub-study The purpose of this research sub-study is to find out the effects of ofatumumab on the development of antibody responses to selected vaccines and keyhole limpet hemocyanin (KLH) neo-antigen in subjects with relapsing multiple sclerosis (RMS).
Recruiting2 awards Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Novartis Investigative Site?
Novartis Investigative Site is a medical facility located in Miami, Florida. This center is recognized for care of Multiple Sclerosis, Obstructive Lung Diseases, Chronic Obstructive Pulmonary Disease, Lung Disease, Arthritis and other specialties. Novartis Investigative Site is involved with conducting 123 clinical trials across 119 conditions. There are 1 research doctors associated with this hospital, such as Melvin Martinez-Castrillon.